Current approaches to diagnosis and treatment of NAFLD PRO.MED.CS Praha a.s. 25:12 7 years ago 4 142 Скачать Далее
BILE ACID SYNTHESIS Biochemistry| Farnesoid X receptor| Role of FXR agonist in biliary cholangitis live biochemistry 8:51 3 years ago 1 153 Скачать Далее
The Re-vival of Bile Acid Based Therapeutics for Children and Adults | Saul Karpen Academic Medical Education 22:43 3 years ago 60 Скачать Далее
NASH (non-alcoholic steatohepatitis) information, diagnostics and treatment Texas Liver Institute 22:11 7 years ago 4 832 Скачать Далее
Paneth cells and their role in innate immunity and shaping the microbiome ImmuneZoom 1:13:11 2 years ago 475 Скачать Далее
Clinical Cuts: Pharmacodynamics - Agonist, partial agonist, antagonist Osmosis from Elsevier 0:40 9 months ago 12 114 Скачать Далее
NAFLD - Simon W. Beaven, MD, PhD | UCLA Digestive Diseases UCLA Health 21:04 7 years ago 2 395 Скачать Далее
Liver-Directed Drugs in the Pipeline for Fibrotic NASH - S. Harrison, MD, FACP, FAASLD Col(ret.) Academic Medical Education 22:55 2 years ago 879 Скачать Далее
EASL Studio S4E22 - JHEP Live: new and promising drugs for NASH on the horizon EASL - Home of Hepatology 33:31 1 year ago 717 Скачать Далее
The evolving landscape of PBC: new therapies and future directions Springer Healthcare IME 13:37 2 months ago 123 Скачать Далее
Exploring Data on Emerging Treatments for Primary Biliary Cholangitis Medscape 30:08 4 weeks ago 2 Скачать Далее
The Liver Meeting 2023 – updates to the current landscape Springer Healthcare IME 17:59 5 months ago 34 Скачать Далее
Fatty Liver Disease: New Therapeutics University of California Television (UCTV) 36:37 6 years ago 111 198 Скачать Далее